Trade Catalyst Pharmaceuticals - CPRX CFD
What is Catalyst Pharmaceuticals (CPRX)?
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company specializes in treatments targeting neuromuscular and neurological disorders, with an emphasis on conditions that have limited therapeutic options. Catalyst's portfolio includes products designed to improve muscle function and quality of life for patients with specific genetic disorders. The company engages in research and development activities to advance its pipeline of drug candidates, often collaborating with academic institutions and other industry partners. Catalyst Pharmaceuticals operates within the specialty pharmaceutical sector, navigating regulatory pathways to obtain approvals for its therapies. Its business model includes both commercializing approved products and progressing investigational drugs through clinical trials to address unmet medical needs in rare disease populations.
Catalyst Pharmaceuticals Stock Price Today: Live Overview
The price today is shaped by current trading dynamics, as Catalyst Pharmaceuticals stands at $24.73. It has seen a low of $24.16 and a high of $24.72 within the day, with a change of -0.6058%.
FAQ: Catalyst Pharmaceuticals (CPRX)
What is the current price of CPRX stock?
Catalyst Pharmaceuticals' current trading value is $24.73.
Does CPRX pay dividends?
Catalyst Pharmaceuticals does not pay dividends.
Does CPRX have a formal corporate presence or regional headquarters in the UAE?
Catalyst Pharmaceuticals does not have a registered presence or office in the UAE and operates through partners only.
What is CPRX best known for?
Catalyst Pharmaceuticals is most famous for developing treatments for rare neuromuscular diseases.
What assets are typically shown together with CPRX?
Commonly shown alongside CPRX: MP Materials Corp., OGE Energy Corp., Robert Walters PLC
Latest shares articles



